UPC Analytics
DEEN
Übersicht · Eingereicht: 19. Sept. 2024

UPC_CoA_540/2024

ENDOLUMINAL LASER ABLATION DEVICE FOR TREATING VEINS

BerufungenHauptberufungCourt of AppealAppeal
Parteien

Kläger

  • biolitec Holding GmbH & Co. KG
Vertreter: Paul Szynka (CBH Rechtsanwälte); Hannes Jacobsen (CBH Rechtsanwälte); Alexander M. Fischer (CBH Rechtsanwälte); Franz Herrmann (Dendorfer & Herrmann)

Beklagte

  • Light Guide Optics Germany GmbH
  • S.I.A. LIGHTGUIDE International
Vertreter: Jörg Schmidt (Wildanger Kehrwald Graf v. Schwerin & Partner mbB); Jan Caspar Maiers (Wildanger Kehrwald Graf v. Schwerin & Partner mbB)
Richter
  • Klaus GrabinskiPresident of the Court of Appeal
  • Peter BlokLegally qualified judge
  • Emmanuel GougéLegally qualified judge and Judge-rapporteur
  • Eric AugardeTechnically qualified judge
  • Max TilmannTechnically qualified judge
Patente
  • EP3685783
CPC-Codes: A61B18/24, A61B2018/2272, A61B17/22012

Sektor: Pharmaceutical & Medical

Ausgang
PI abgelehnt
Eingereicht: 19. Sept. 2024
Erste Entscheidung: 24. Feb. 2025
Sprache:

Court of Appeal rejected Biolitec's appeal against the Düsseldorf Local Division's refusal to grant a preliminary injunction. The CoA upheld the first-instance order, finding that Biolitec had not demonstrated the necessity of provisional measures: proceedings on the merits could be awaited; the status quo on the market had existed for years before the patent was granted; and Biolitec failed to demonstrate sufficient evidence of urgency regarding stocking or tender-related harm. Biolitec was ordered to bear the costs of the appeal proceedings.

Im UPC-Register öffnen